Philippe Lesprit

2.9k total citations · 1 hit paper
60 papers, 1.8k citations indexed

About

Philippe Lesprit is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Philippe Lesprit has authored 60 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 22 papers in Infectious Diseases and 14 papers in Surgery. Recurrent topics in Philippe Lesprit's work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Pneumonia and Respiratory Infections (9 papers). Philippe Lesprit is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Pneumonia and Respiratory Infections (9 papers). Philippe Lesprit collaborates with scholars based in France, United States and Netherlands. Philippe Lesprit's co-authors include Patrick Legrand, Christian Brun‐Buisson, Bertrand Godeau, Jean‐Michel Molina, Romain K. Gherardi, François‐Jérôme Authier, Lennie Derde, A. Therby, J.P. Bru and Keyvan Razazi and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

Philippe Lesprit

58 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial

2014 315 citations Philippe Lesprit, J.P. Bru et al. profile →

Peers

Countries citing papers authored by Philippe Lesprit

Since Specialization

Citations

This map shows the geographic impact of Philippe Lesprit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Lesprit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Lesprit more than expected).

Fields of papers citing papers by Philippe Lesprit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Lesprit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Lesprit. The network helps show where Philippe Lesprit may publish in the future.

Co-authorship network of co-authors of Philippe Lesprit

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Lesprit. A scholar is included among the top collaborators of Philippe Lesprit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Lesprit. Philippe Lesprit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Utilization of macrolides. State of the art 2022 Spilf and GPIP 2022 ·Infectious Diseases Now ·J.‐P. Stahl, Bernard Castan, É. Bonnet, (unknown), Robert Cohen, S. Diamantis, Albert Faye, Hikombo Hitoto, Nahéma Issa, Philippe Lesprit, Laurence Maulin, (unknown), (unknown), C. Strady, Emmanuelle Varon, Renaud Verdon, Fanny Vuotto, Charlotte Welker, R. Gauzit	0
2	Electronic medical record alert increases HIV screening rates: the Foch hospital pilot POP-up project 2022 ·BMC Health Services Research ·Alexandre Vallée, (unknown), Julie Trichereau, (unknown), Erwan Fourn, C. Majerholc, Philippe Lesprit, (unknown), (unknown), (unknown), Marc Vasse, David Zucman	1
3	Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendations 2021 ·Infectious Diseases Now ·R. Gauzit, Bernard Castan, É. Bonnet, J.P. Bru, Robert Cohen, S. Diamantis, Albert Faye, Hikombo Hitoto, Nahéma Issa, David Lebeaux, Philippe Lesprit, Laurence Maulin, (unknown), (unknown), C. Strady, Emmanuelle Varon, Renaud Verdon, Fanny Vuotto, Charlotte Welker, J.‐P. Stahl	20
4	Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign 2021 ·Public Health ·Alexandre Vallée, (unknown), Brigitte Bonan, Philippe Lesprit, François Parquin, É. Catherinot, Jacques Choucair, (unknown), (unknown), (unknown), Charles Cerf, David Zucman, Erwan Fourn	10
5	A strain uncoloured by Gram staining in a pleural fluid 2021 ·Clinical Microbiology and Infection ·(unknown), (unknown), Philippe Lesprit, Marc Vasse, Sabine Pereyre	3
6	Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19 2020 ·American Journal of Infection Control ·Éric Farfour, (unknown), Laurent Dortet, Morgan Le Guen, Charles Cerf, (unknown), Rémy A. Bonnin, Marc Vasse, Philippe Lesprit	49
7	Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice 2019 ·Médecine et Maladies Infectieuses ·(unknown), Vincent Launay‐Vacher, Alexandre Bleibtreu, Perrine Bortolotti, Emmanuel Faure, (unknown), R. Gauzit, Marius Gilbert, Philippe Lesprit, Rafaël Mahieu, Vanina Meyssonnier, (unknown), (unknown), Dominique Salmon‐Céron, S. Alfandari, Adrien Lemaignen	20
8	Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections 2019 ·Médecine et Maladies Infectieuses ·J.P. Bru, S. Alfandari, Alexandre Bleibtreu, P. Chavanet, R. Gauzit, Xavier Lescure, Philippe Lesprit, Pierre Tattevin	2
9	Impact of rapid diagnostic tests on the management of patients presenting with Enterobacteriaceae bacteremia 2018 ·Médecine et Maladies Infectieuses ·Éric Farfour, Anis Larbi, (unknown), (unknown), (unknown), P Cahen, Marc Vasse, Philippe Lesprit	4
10	Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice? 2015 ·International Journal of Infectious Diseases ·B. Pilmis, Tristan Delory, Matthieu Groh, Emmanuel Weiss, A. Emirian, Hervé Lécuyer, Philippe Lesprit, J.-R. Zahar	10
11	Protracted outbreak of multidrug-resistant Acinetobacter baumannii after intercontinental transfer of colonized patients 2013 ·Archive ouverte UNIGE (University of Geneva) ·Caroline Landelle, Patrick Legrand, Philippe Lesprit, Florence Cizeau, (unknown), (unknown), (unknown), (unknown), Emmanuelle Girou, Christian Brun‐Buisson	2
12	Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood cultures 2010 ·Clinical Microbiology and Infection ·Vincent Cattoir, (unknown), (unknown), C. Rioux, Pierre Legrand, Emmanuelle Girou, Philippe Lesprit	23
13	New Bacteriological Patterns in Primary Infected Aorto-iliac Aneurysms: A Single-centre Experience 2010 ·European Journal of Vascular and Endovascular Surgery ·(unknown), Philippe Lesprit, J. Marzelle, Éric Allaire, J.-P. Becquemin, Pascal Desgranges	48
14	In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid 2006 ·Journal of Antimicrobial Chemotherapy ·(unknown), Philippe Lesprit, Christine Lascols, Erick Denamur, Pierre Legrand, C.-J. Soussy, Emmanuelle Cambau	27
15	Tuberculosis treatment duration in France: From guidelines to daily practice 2006 ·European Journal of Internal Medicine ·Pierre Tattevin, (unknown), Philippe Lesprit, Christophe Billy, F. Roblot, S. Alfandari, Louis Bernard, É. Rouveix, E. Bouvet	14
16	Severe soft tissue infections of the extremities in patients admitted to an intensive care unit 2005 ·Clinical Microbiology and Infection ·J.-R. Zahar, (unknown), Philippe Lesprit, C. Brun‐Buisson	23
17	Role of the Quorum-sensing System in Experimental Pneumonia due to Pseudomonas aeruginosa in Rats 2003 ·American Journal of Respiratory and Critical Care Medicine ·Philippe Lesprit, François Faurisson, Olivier Join‐Lambert, Françoise Roudot‐Thoraval, Maryline Foglino, C Vissuzaine, Claude Carbón	58
18	Pulmonary Hypertension in POEMS Syndrome: A New Feature Mediated by Cytokines 1998 ·American Journal of Respiratory and Critical Care Medicine ·Philippe Lesprit, Bertrand Godeau, François‐Jérôme Authier, Martin Soubrier, Mathieu Zuber, C. Larroche, Jean‐Paul Viard, B. Wechsler, Romain K. Gherardi	112
19	Prevalence of and Risk Factors for Clostridium difficile Colonization at Admission to an Infectious Diseases Ward 1997 ·Clinical Infectious Diseases ·Yvan Hutin, I Casin, Philippe Lesprit, Charlotte Welker, J.M. Decazes, Philippe Lagrange, J Modaï, Jean‐Michel Molina	31
20	Acute Arterial Obliteration: A New Feature of the POEMS Syndrome? 1996 ·Medicine ·Philippe Lesprit, François‐Jérôme Authier, Romain K. Gherardi, Laurent Bélec, Daniel Paris, D Méllière, Annette Schaeffer, Bertrand Godeau	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact